Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,900 | 8,640 | 19,696 | 5,180 | 6,331 |
| Marketable Securities | 9,000 | 9,000 | N/A | N/A | N/A |
| TOTAL | $16,081 | $17,849 | $19,798 | $5,392 | $6,475 |
| Non-Current Assets | |||||
| PPE Net | 130 | 147 | 172 | 198 | 235 |
| Other Non-Current Assets | 0 | 0 | 2 | 2 | 2 |
| TOTAL | $130 | $147 | $174 | $200 | $237 |
| Total Assets | $16,211 | $17,996 | $19,972 | $5,592 | $6,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 177 | 358 | 366 | 416 | 155 |
| Accrued Expenses | 1,018 | 913 | 1,126 | 767 | 877 |
| TOTAL | $1,342 | $1,510 | $1,958 | $1,679 | $1,411 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 147 | 239 | 464 | 491 | 370 |
| TOTAL | $N/A | $N/A | $N/A | $27 | $N/A |
| Total Liabilities | $1,342 | $1,510 | $1,958 | $1,706 | $1,411 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,684 | 11,683 | 338,154 | 321,627 | 158,670 |
| Common Shares | 1 | 1 | 32 | N/A | 16 |
| Retained earnings | -35,574 | -33,515 | -31,554 | -17,157 | -15,445 |
| Other shareholders' equity | 9,840 | 9,771 | 9,896 | 9,726 | 9,575 |
| TOTAL | $14,869 | $16,486 | $18,014 | $3,886 | $5,301 |
| Total Liabilities And Equity | $16,211 | $17,996 | $19,972 | $5,592 | $6,712 |